US Patent

US10918723 — Colon cleansing compositions and methods of use

Method of Use · Assigned to Norgine BV · Expires 2033-09-10 · 7y remaining

Vulnerability score 45/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects methods and kits for using colon cleansing compositions, including those associated with the Infuvite Adult solution.

USPTO Abstract

The invention also provides methods an kits associated with, or making use of the solutions, and compositions for the preparation of the solutions.

Drugs covered by this patent

Infuvite Adult (ASCORBIC ACID)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2310`	—	Infuvite Adult

Patent Metadata

Patent number: US10918723
Jurisdiction: US
Classification: Method of Use
Expires: 2033-09-10
Drug substance claim: No
Drug product claim: No
Assignee: Norgine BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.